08/13/2024 / Saint Jude's Children Hospital
Scientists at St. Jude Children’s Research Hospital demonstrated the value of DNA methylation patterns for identifying the root cause of developmental and epileptic encephalopathies (DEEs). Their new study shows that specific gene methylation and genome-wide methylation “episignatures” can help identify the genes that cause DEE.
08/13/2024 / Weill Cornell Medicine
According to a new study led by researchers at Weill Cornell Medicine and Linköping University in Sweden, the general anesthetic propofol may hold the keys to developing new treatment strategies for epilepsy and other neurological disorders.
08/13/2024 / UCSF Weill Institute for Neurosciences
Epilepsy specialists have developed a method to predict 24-hour seizure risk. The researchers showed that the storm of brain activity characterizing a seizure is presaged by abnormal communication between specific areas of the brain.
07/16/2024 / International League Against Epilepsy
The ILAE Sharp Waves Podcasts focuses on the Human Intracerebral EEG Platform, which is a cloud-based, collaborative environment that encourages the sharing of data and the conducting of research with state-of-the-art methodologies and software. This platform can be used to improve research methods and promote data sharing in order to best drive epilepsy research forward.
07/16/2024 / The Transmitter
A recent study finds that a small posterior part of the hippocampus may play a role in causing seizures, specifically in individuals who do not respond to anti-seizure medications or tissue ablation in the hippocampus.
07/16/2024 / Stanford Medicine
A class of blood pressure medications, called angiotensin receptor blockers (ARBs), appear to help lower seniors’ risk of developing epilepsy, a new study finds.
05/21/2024 / Penn Medicine News
The findings suggest a promising target for developing treatments for epilepsy and preventing the downstream effects of seizures.
05/21/2024 / International League Against Epilepsy
Although 80% of people with epilepsy live in low- and middle-income countries (LMICs), most epilepsy research originates in high-income regions.
05/21/2024 / Stoke Therapeutics
The improvements in skills like communication, behavior, socialization, and movement distinguish this approach from anything seen to date and mark the entry into a new era in the treatment of Dravet syndrome.